Scipher Medicine Corporation

BiotechnologySeries DWaltham, USsciphermedicine.com

Latest round

Series D

Last raised

Jan 2022

Total raised

$222M

Investors

13

About Scipher Medicine Corporation

Based in Massachusetts, US, Scipher Medicine Corporation (Scipher Medicine) was founded in 2014 by co-founders Dr. Joe Loscalzo and Dr. Albert-Laszlo Barabasi. In 2003, the founders started building the map of human disease biology that explains how proteins expressed from the human genome interact to cause specific diseases. In 2016, researchers of the company began to develop predictive drug response tests. After studying and surveying the healthcare community to identify major therapeutic and financial pressure points, in 2017 Scipher applied its analysis to create a blood test for predicting medication response to anti-TNF therapies. Scipher Medicine Corporation develops a suite of drug development platforms that analyze genetic information to determine suitable therapeutics using machine learning and artificial intelligence. The firm's offerings include ScipherIx, a protein-mapping platform for identifying patient population subgroups; ScipherDx, a drug response prediction platform; and ScipherRx, a drug development platform utilizing gene expression data and applying them to ScipherIx. The company plans to extend commercial efforts for its patient molecular signature test, PrismRA®, to ensure that rheumatoid arthritis patients are administered effective personalized therapy from the onset, as well as data partnerships to explore novel treatment targets based on its broad and growing patient clinical-genomic database created from studied patients.

Who invested in Scipher Medicine Corporation

13 investors across 5 rounds

See all investors in Scipher Medicine Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jan 30, 2022

    Amount

    $110M

    Investors

    Locked

  2. Series C

    Mar 24, 2021

    Amount

    $82M

    Investors

    Locked

  3. Series B

    Feb 19, 2020

    Amount

    Undisclosed

    Investors

    Locked

  4. Series B

    May 8, 2019

    Amount

    $20M

    Investors

    Locked

  5. Series A

    Sep 6, 2018

    Amount

    $10M

    Investors

    Locked

Questions about Scipher Medicine Corporation

Who invested in Scipher Medicine Corporation?

Scipher Medicine Corporation has 13 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Scipher Medicine Corporation raised?

Scipher Medicine Corporation has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Scipher Medicine Corporation last raise money?

Scipher Medicine Corporation's most recent round on record is a Series D, in Jan 2022.

What does Scipher Medicine Corporation do?

Based in Massachusetts, US, Scipher Medicine Corporation (Scipher Medicine) was founded in 2014 by co-founders Dr.

Where is Scipher Medicine Corporation headquartered?

Scipher Medicine Corporation is headquartered in Waltham, US.

Which VCs invest in companies like Scipher Medicine Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Scipher Medicine Corporation's stage. Their profiles are linked below.

Raising like Scipher Medicine Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.